NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapy
- Author(s)
- Bazinet, A; Burger, J; Ferrajoli, A; Kantarjian, H; Jain, N; Yilmaz, M; Swaminathan, M; Keating, M; Thompson, PA; Wierda, WG;
- Details
- Publication Year 2026-06-23,Volume 10,Issue #12,Page 4113-4116
- Journal Title
- Blood Advances
- Publication Type
- Research article
- Publisher
- American Society of Hematology
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1182/bloodadvances.2026020243
- Open Access at Publisher's Site
https://doi.org/10.1182/bloodadvances.2026020243- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-04-02 12:29:59
Last Modified: 2026-06-25 06:02:47